These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37813566)
1. Female advantage in neoadjuvant pancreatic cancer therapy: is it down to macrophages? Michl P; Roth L Gut; 2024 Jan; 73(2):214-215. PubMed ID: 37813566 [No Abstract] [Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for pancreatic cancer. Vinciguerra V Oncology (Williston Park); 2011 Feb; 25(2):192-3. PubMed ID: 21456392 [No Abstract] [Full Text] [Related]
5. [Impact of neoadjuvant therapy on the perioperative complications of pancreatic cancer]. Shi S; Yu XJ Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):708-711. PubMed ID: 33721948 [TBL] [Abstract][Full Text] [Related]
6. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis. Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382 [TBL] [Abstract][Full Text] [Related]
8. [Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer]. Seufferlein T; Michalski C Chirurg; 2022 May; 93(5):441-445. PubMed ID: 35376964 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer. Keedy VL; Berlin J Curr Treat Options Oncol; 2006 Sep; 7(5):381-8. PubMed ID: 16904055 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266 [TBL] [Abstract][Full Text] [Related]
11. A commentary on 'Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study'. Zhong F; Xieb C; Peng X; Luo J; Yang H Int J Surg; 2024 Mar; 110(3):1331-1332. PubMed ID: 38051933 [No Abstract] [Full Text] [Related]
12. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG; JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170 [TBL] [Abstract][Full Text] [Related]